Watch List for Investors: Tenneco (NYSE:TEN), Brightcove (NASDAQ:BCOV), Rose Rock Midstream, L.P. (NYSE:RRMS), Delcath Systems (NASDAQ:DCTH)

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares advanced 6.59% in last trading session and ended the day at $2.75. RIGL has a return on assets of -40.20%. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) quarterly performance is 2.23%.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) announced that the first of two Phase 3 clinical studies of fostamatinib in immune thrombocytopenic purpura (ITP) completed patient enrollment this month. The results from this first study are expected in the middle of 2016, with the results from the second study expected shortly thereafter.

Tenneco Inc. (NYSE:TEN) ended the last trading day at $38.21. Company weekly volatility is calculated as 3.31% and price to cash ratio as 10.04. Tenneco Inc. (NYSE:TEN) showed a weekly performance of 0.74%.

On 27 January, Tenneco Inc. (NYSE:TEN). has opened enrollment for its 2016 Expert Plus dealer loyalty program, which the firm said is designed to help automotive service businesses increase their share of the undercar service market.

On 29 January, Brightcove Inc. (NASDAQ:BCOV) shares advanced 2.78% and was closed at $5.54. BCOV EPS growth in last 5 year was -13.60%. Brightcove Inc. (NASDAQ:BCOV) year to date (YTD) performance is -10.65%.

Brightcove Inc (NASDAQ:BCOV) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Tuesday, Analyst Ratings.Net reports. The brokerage currently has a $6.75 price target on the stock. Zacks Investment Research‘s target price would suggest a potential upside of 10.66% from the stock’s current price.

Rose Rock Midstream, L.P. (NYSE:RRMS) shares decreased -9.70% in last trading session and ended the day at $10.98. RRMS Gross Margin is 19.40% and its has a return on assets of 3.60%. Rose Rock Midstream, L.P. (NYSE:RRMS) quarterly performance is -58.53%.

Rose Rock Midstream, L.P. (NYSE:RRMS) announced that the Board of Directors of its general partner has declared a cash distribution with respect to the fourth quarter of 2015 of $0.66 per unit, or $2.64 per unit on an annualized basis. This distribution represents an increase of approximately 6.5% over the distribution of $0.62 per unit with respect to the fourth quarter of 2014. The distribution will be paid on February 12, 2016 to all unitholders of record on February 2, 2016.

Delcath Systems, Inc. (NASDAQ:DCTH) caters to the Healthcare space. Its weekly performance is -28.05%. On the last day of trading company shares ended up at $0.29. Delcath Systems, Inc. (NASDAQ:DCTH) distance from 50-day simple moving average (SMA50) is -5.19%.

Delcath Systems, Inc. (NASDAQ:DCTH) announces the initiation of a Phase 3 clinical trial of Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) for the treatment of patients with hepatic dominant ocular melanoma (OM).